← Compound index
COMPOUND RECORD / ADK-677

ADK-677АДК-677

ADK-677 is an experimental N-substituted adamantylpiperazine. A historical screen reported weak inhibition of hepatic monooxygenases, enzymes involved in drug metabolism. The source does not identify the N-substituent.

Source linked

What the studies found

Animal research · 1996

Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects

Findings for this preparation

ADK-677 was described as a weak inhibitor of hepatic monooxygenases in the historical experimental screen. These findings do not establish a human clinical effect.

Study notes · methods, sources and limitations

Participants or model Mouse hepatic-enzyme screening and sensitized guinea-pig anaphylaxis experiments

Important limitations

  • Original structures and tables require checking against the scan; transcription errors are possible. Enzyme induction does not establish detoxification benefits or predict safe human drug combinations. Animal anaphylaxis results are not evidence for treating allergy in people; proposed adjunct uses were development suggestions.

Doctoral dissertation author’s abstract. Moscow, 1996 · Dissertation; OCR reproduction

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About ADK-677

Research background

An N-substituted adamantylpiperazine in the historical hepatic-enzyme screen. Exact substitution requires recovery of the original structural record.

Compound class
Archival adamantane screening lead
Research collection
Actoprotection & occupational pharmacology · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

Human efficacy results unavailable

Study methods

Source-specific animal, chemistry, patent or dissertation evidence

Independent replication

Independent replication not established; translations are not separate experiments

Source access

Access and review depth appear with each linked record

Safety evidence

Human safety and interactions not established; animal activity is not a safe-use recommendation

Open a topic for the evidence assessment.

More findings, background and history

Chlodantane, Cyclontane and the ADK research program ↗

What remains unclear

The original report and protocol would clarify group sizes, background treatment and translation. Independent replication and equivalence to current products remain uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗
03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Animal research · 1996

Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects

ADK-677 was described as a weak inhibitor of hepatic monooxygenases in the historical experimental screen. These findings do not establish a human clinical effect.

Study notes and original source
1996Animal / experimentalRussian-language source

Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects

· Dissertation; OCR reproduction

Format: Dissertation abstract transcription · Reviewed: See scope

T. G. Khlopushina · Doctoral dissertation author’s abstract. Moscow, 1996

ADK-559/591/676/677 weakly inhibited hepatic monooxygenases; ADK-709/790/828/829/910/918 induced P450. The author also reports fewer anaphylaxis deaths with ADK-828 and ADK-829 in guinea pigs. Different controls and OCR table ambiguities prevent a reliable cross-compound ranking.

Population / setting
Mouse hepatic-enzyme screening and sensitized guinea-pig anaphylaxis experiments
Source reviewed
Selected source passages checked; complete methods and risk of bias not appraised.
Study limitations
  • Original structures and tables require checking against the scan; transcription errors are possible.
  • Enzyme induction does not establish detoxification benefits or predict safe human drug combinations.
  • Animal anaphylaxis results are not evidence for treating allergy in people; proposed adjunct uses were development suggestions.

Reviewed 2026-10-03.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗